C H Schenck, M W Mahowald. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » AdultAntidepressive Agents, Second-Generation/administration & dosageAntidepressive Agents, Second-Generation/therapeutic useAntiparkinson Agents/administration & dosageAntiparkinson Agents/therapeutic useBupropion/administration & dosageBupropion/therapeutic useDepressive Disorder, Major/complicationsDepressive Disorder, Major/drug therapyDrug Therapy, CombinationFeeding and Eating Disorders/complicationsFeeding and Eating Disorders/drug therapyFemaleHumansLevodopa/administration & dosageLevodopa/therapeutic useMaleSubstance-Related Disorders/complicationsTrazodone/administration & dosageTrazodone/therapeutic useWakefulness/physiology
Substances: See more » Antidepressive Agents, Second-GenerationAntiparkinson AgentsBupropionLevodopaTrazodone
Year: 2000 PMID: 10947025
Source DB: PubMed Journal: Sleep ISSN: 0161-8105 Impact factor: 5.849